### ğŸ« Pulmonary Medicine: Moderate to Severe Obstructive Sleep Apnea Diagnosis

#### âœ… True Statements
1. **Home sleep apnea testing (HSAT)** is the most appropriate initial diagnostic test for **obstructive sleep apnea (OSA)** in patients with a high probability of at least moderate disease who do not have significant **cardiopulmonary** or **neuromuscular disease**.
2. **HSAT** is less sensitive in suspected mild OSA, for which **in-laboratory polysomnography** is the preferred test.
3. **Polysomnography** is preferred over HSAT in patients with comorbid conditions such as **heart failure**, **neuromuscular disease**, or **advanced pulmonary disease**.
4. Clinical features suggesting at least moderate OSA include **sleep-related choking or gasping**, **loud snoring**, **daytime sleepiness**, and **hypertension**.
5. Both **HSAT** and **polysomnography** provide the **apnea-hypopnea index (AHI)**, the best composite metric of OSA disease severity.
6. An **AHI of 5â€“14 events per hour** indicates **mild OSA**, **15â€“30 events per hour** indicates **moderate OSA**, and **more than 30 events per hour** indicates **severe OSA**.
7. **Mandibular advancement devices** do not reduce the AHI as reliably as positive airway pressure and are most appropriate for **mild to moderate OSA**.
8. **Upper airway surgery**, including **tonsillectomy**, is variably effective and not considered **first-line therapy** for OSA in adults.

#### ğŸ’¬ Extra
1. HSAT is particularly suitable when there is **high pretest probability** of moderateâ€“severe OSA (for example, **witnessed nocturnal gasping**, **enlarged neck circumference**, and a **crowded oropharynx**).
7. **Mandibular advancement device** referral is **premature** before confirming an OSA diagnosis.
8. **Tonsillectomy** may reduce obstruction from enlarged tonsils but is **rarely effective as standalone therapy** for adult OSA.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #ObstructiveSleepApnea #HSAT #Polysomnography #AHI #AmbulatoryCare

#### ğŸ“š Reference
Hudgel DW, Patel SR, Ahasic AM, et al; American Thoracic Society Assembly on Sleep and Respiratory Neurobiology. The role of weight management in the treatment of adult obstructive sleep apnea. *Am J Respir Crit Care Med*. 2018;198:e70-87. PMID: 30215551 doi:10.1164/rccm.201807-1326ST

#### ğŸ†” Question ID
PMMCQ24004

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP 19: Pulmonary Medicine â€” Sleep Medicine, Obstructive Sleep Apnea, Treatment of OSA, Weight Loss and Behavioral Modifications for OSA

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Patient education** is recommended for all patients newly diagnosed with **obstructive sleep apnea (OSA)**.
2. **Weight loss** should be recommended to all patients with **OSA** who are **overweight** or **obese**.
3. In **minimally symptomatic mild OSA**, **weight loss** may be the **preferred therapy**.
4. Additional measures for mild OSA include **reducing alcohol intake before bedtime**, **avoiding sedating medications**, and **avoiding a supine posture** if OSA is position dependent.
5. **Bariatric surgery referral** should be considered for **BMI â‰¥35** when **positive airway pressure (PAP)** therapy is **not beneficial** or **not tolerated**.
6. Trials of **obesity medications** (including **glucagon-like peptide-1 [GLP-1] receptor agonists**) show **benefit in OSA** and its sequelae.
7. **Tirzepatide** is **FDA-approved** for **OSA treatment** and is also indicated for **type 2 diabetes mellitus** and **weight loss**.

#### ğŸ’¬ Extra
5. Bariatric referral applies **after failure or intolerance of PAP** in patients with **BMI â‰¥35**.  
6. Pharmacologic weight-loss options are **emerging adjuncts** to lifestyle measures for OSA.  
7. **Tirzepatide** is the **first FDA-approved obesity medication for OSA**.

---

#### ğŸ–¼ï¸ Supplemental Figure
<figure>
  <img src="Manage moderate to severe obstructive sleep apnea.jpg"
       alt="Oropharyngeal endoscopic view labeled with low-hanging soft palate, tonsils, and tongue base, illustrating upper-airway crowding relevant to obstructive sleep apnea." />
  <figcaption>
    <strong>Oropharyngeal crowding relevant to obstructive sleep apnea (OSA).</strong>
    Endoscopic image showing a low-hanging soft palate, tonsils, and tongue base that contribute to a crowded upper airwayâ€”a common anatomic risk factor for OSA.
  </figcaption>
</figure>
